Imugene Limited (AU:IMU) has released an update.
Imugene Limited, a biotech firm specializing in immuno-oncology, announced a strategic partnership with Kincell Bio and is set to host an investor webinar to discuss the collaboration details. The webinar is scheduled for April 18, 2024, and will feature key executives from both companies. Shareholders and investors are invited to register online to participate in the live event, with a recording to be made available post-session.
For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.
